NCOA4-mediated ferritinophagy: emerging role and novel therapeutic target in precision oncology
Authors:
Top Cited Papers
- 11 April 2026
- journal article
- review article
- Published by Taylor & Francis in Autophagy
- Vol. 22 (8) , 1-17
Abstract
Iron is vital for life but can be toxic in excess by forming reactive oxygen species. Ferroptosis, a type of regulated cell death, relies on iron-dependent lipid peroxidation and requires a labile iron pool (LIP) in cells. Ferritin stores iron safely, and its degradation increases the LIP. Ferritinophagy, the autophagic breakdown of ferritin, is crucial for releasing stored iron to trigger ferroptosis. This review examines ferritinophagy's molecular mechanisms, highlighting NCOA4 (nuclear receptor coactivator 4) as the main receptor targeting ferritin for lysosomal degradation. It also discusses the regulatory network controlling NCOA4, including transcriptional factors like TP53/p53 and MYC/c-Myc, RNA-binding proteins, and post-translational modifications such as ubiquitination. We explore ferritinophagy-induced ferroptosis as a promising anti-cancer approach. Research shows that various natural compounds, repurposed drugs, and new metal complexes can induce tumor cell death by activating the NCOA4-ferritinophagy pathway, which is crucial for overcoming therapeutic resistance in many cancers. Understanding this pathway highlights the relationship between iron metabolism, macroautophagy/autophagy, and cell death, offering a foundation for new treatments for cancer and iron-related diseases.Abbreviation: FTH1: ferritin heavy chain 1; GPX4: glutathione peroxidase 4; GSH: glutathione; HIF: hypoxia-inducible factor; LIP: labile iron pool; MAPK/JNK: mitogen-activated protein kinase; NCOA4: nuclear receptor coactivator 4; PUFAs: polyunsaturated fatty acids; SLC7A11: solute carrier family 7 member 11; TFRC: transferrin receptor; TFEB: transcription factor EB.Keywords
Funding Information
- the Science and Technology Support Program of Guizhou Province (QKH-ZK[2023]506)
- Shenzhen Medical Research Funds (C2303002)
- Research Grants Council of the Hong Kong Special Administrative Region, China (C4024-22GF)
- Research Grants Council of the Hong Kong Special Administrative Region, China (R4007-23)
- Health and Medical Research Fund of Food and Health Bureau of Hong Kong (08192166)
This publication has 135 references indexed in Scilit:
- Lactylation in cancer biology: Unlocking new avenues for research and therapyCancer Communications, 2025
- PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to TreatmentMedcomm, 2025
- Targeted ferritinophagy in gastrointestinal cancer: from molecular mechanisms to implicationsArchives of Toxicology, 2024
- Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagyThe Prostate, 2023
- 2D MoS2Nanosheets Induce Ferroptosis by Promoting NCOA4‐Dependent Ferritinophagy and Inhibiting FerroportinSmall, 2023
- Ferritin‐Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer TherapyAdvanced Materials, 2022
- pH‐Sensitive Molecular‐Switch‐Containing Polymer Nanoparticle for Breast Cancer Therapy with Ferritinophagy‐Cascade Ferroptosis and Tumor Immune ActivationAdvanced Healthcare Materials, 2021
- TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinomaJournal of Cellular Physiology, 2021
- Ferritinophagy is not required for colon cancer cell growthCell Biology International, 2020
- Imaging Protein-Protein Interactions Using Fluorescence Resonance Energy Transfer MicroscopyMethods, 2001